FdaApplication

NDA 219379

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSPRINGWORKS THERAPEUTICS INC
application_typeNDA
approval_date2025-02-11

Products (3)

ProductActive ingredientStrengthDosage form
GOMEKLIMIRDAMETINIB4MGTABLET, FOR SUSPENSION;ORAL
GOMEKLIMIRDAMETINIB1MGTABLET, FOR SUSPENSION;ORAL
GOMEKLIMIRDAMETINIB3MGTABLET, FOR SUSPENSION;ORAL

3 products